Q1 2024 Holdings
Filed 2024-05-15 | 114 holdings | $3.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $237.0M | 2,498,448 | 6.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $153.9M | 2,367,816 | 3.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $145.5M | 1,054,900 | 3.7% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $130.8M | 3,987,500 | 3.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $119.1M | 298,500 | 3.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $113.8M | 230,000 | 2.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $112.7M | 505,000 | 2.9% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $96.8M | 179,250 | 2.5% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $93.3M | 1,177,500 | 2.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $90.3M | 229,250 | 2.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $84.4M | 1,232,500 | 2.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $82.9M | 1,774,938 | 2.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $82.8M | 596,750 | 2.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $80.3M | 103,250 | 2.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $76.8M | 662,500 | 1.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $76.4M | 285,931 | 1.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $73.2M | 1,059,750 | 1.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $72.1M | 220,000 | 1.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $66.0M | 1,522,893 | 1.7% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $61.9M | 647,300 | 1.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $61.2M | 1,522,238 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $57.6M | 1,372,185 | 1.5% |
| Phreesia Inc(PHR) | COM | 71944F106 | $56.6M | 2,365,000 | 1.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $54.8M | 320,000 | 1.4% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $54.3M | 137,250 | 1.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $54.1M | 1,255,577 | 1.4% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $53.9M | 8,835,000 | 1.4% |
| Merus N V | COM | N5749R100 | $51.6M | 1,146,560 | 1.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $51.6M | 1,764,505 | 1.3% |
| Humana Inc(HUM) | COM | 444859102 | $51.1M | 147,408 | 1.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $46.6M | 1,856,564 | 1.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $45.5M | 392,250 | 1.2% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $44.0M | 135,000 | 1.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $43.8M | 290,000 | 1.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $42.4M | 327,600 | 1.1% |
| Azenta Inc(AZTA) | COM | 114340102 | $41.9M | 694,750 | 1.1% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $39.4M | 1,676,500 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $37.2M | 1,150,123 | 0.9% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $37.1M | 3,540,000 | 0.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $36.5M | 244,000 | 0.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $32.8M | 1,299,888 | 0.8% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $31.4M | 2,110,000 | 0.8% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $30.8M | 1,055,500 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $29.8M | 923,681 | 0.8% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $29.5M | 4,780,000 | 0.7% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $29.4M | 985,000 | 0.7% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $28.3M | 2,080,000 | 0.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $28.2M | 3,681,174 | 0.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $28.0M | 130,500 | 0.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $28.0M | 499,486 | 0.7% |